Adtalem Global Education Inc. (ATGE) 10-Year Financial Performance & Capital Metrics

ATGE • • Industrial / General

Consumer DefensiveEducation & TrainingHigher Education & Professional TrainingMedical & Healthcare Education

AboutAdtalem Global Education Inc. provides workforce solutions worldwide. It operates through three segments, Chamberlain, Walden, and Medical and Veterinary. The Chamberlain segment offers degree and non-degree programs in the nursing and health professions postsecondary education industry. This segment operates Chamberlain University. The Walden segment offers online certificates, bachelor's, master's, and doctoral degrees, including nursing, education, counseling, business, psychology, public health, social work and human services, public administration and public policy, and criminal justice. This segment also operates Walden University. The Medical and Veterinary segment provides degree and non-degree programs in the medical and veterinary postsecondary education industry. This segment operates American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine. The company was formerly known as DeVry Education Group Inc. and changed its name to Adtalem Global Education Inc. in May 2017. Adtalem Global Education Inc. was incorporated in 1987 and is based in Chicago, Illinois.Show more

Revenue $1.79B +12.9%
EBITDA $393M +34.6%
Net Income $237M +73.3%
EPS (Diluted) 6.07 +79.1%
Gross Margin 56.86% +1.7%
EBITDA Margin 22% +19.3%
Operating Margin 19.1% +39.4%
Net Margin 13.26% +53.6%
ROE 16.92% +74.8%
ROIC 12.8% +60.2%
Debt/Equity 0.54 -12.8%
Interest Coverage 6.53 +91.5%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Strong Piotroski F-Score: 8/9
✓FCF machine: 16.1% free cash flow margin
✓High quality earnings: Operating CF exceeds net income
✓Strong 5Y sales CAGR of 15.6%
✓Share count reduced 4.9% through buybacks
✓Healthy 5Y average net margin of 11.7%

✗Weaknesses

No significant weaknesses identified

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-0.66%

5Y15.6%

3Y8.97%

TTM12.24%

Profit (Net Income) CAGR

10Y5.42%

5Y-

3Y-8.65%

TTM46.24%

EPS CAGR

10Y10.99%

5Y6.17%

3Y-

TTM51.25%

ROCE

10Y Avg7.18%

5Y Avg7.81%

3Y Avg10.43%

Latest15.19%

Peer Comparison

Medical & Healthcare Education

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
ATGEAdtalem Global Education Inc.	4.26B	117.39	19.34	12.85%	13.74%	17.29%	6.74%	0.54
AFYAAfya Limited	674.82M	14.39	2.08	14.9%	20.08%	15.24%	100%	0.74

Profit & Loss

	Jun 2016	Jun 2017	Jun 2018	Jun 2019	Jun 2020	Jun 2021	Jun 2022	Jun 2023	Jun 2024	Jun 2025
Sales/Revenue+	1.84B	1.81B	1.23B	1.24B	866.43M	899.25M	1.38B	1.45B	1.58B	1.79B
Revenue Growth %	-0.03%	-0.02%	-0.32%	0.01%	-0.3%	0.04%	0.54%	0.05%	0.09%	0.13%
Cost of Goods Sold+	986.78M	962.19M	645.6M	623.54M	457.17M	457.9M	659.78M	648.49M	698.55M	771.43M
COGS % of Revenue	0.54%	0.53%	0.52%	0.5%	0.53%	0.51%	0.48%	0.45%	0.44%	0.43%
Gross Profit+	856.76M	847.61M	585.61M	616.15M	409.26M	441.34M	722.07M	802.34M	886.1M	1.02B
Gross Margin %	0.46%	0.47%	0.48%	0.5%	0.47%	0.49%	0.52%	0.55%	0.56%	0.57%
Gross Profit Growth %	-0.06%	-0.01%	-0.31%	0.05%	-0.34%	0.08%	0.64%	0.11%	0.1%	0.15%
Operating Expenses+	654.05M	618.15M	373.06M	400.41M	299.19M	330.94M	645.32M	634.17M	669.05M	675.32M
OpEx % of Revenue	0.35%	0.34%	0.3%	0.32%	0.35%	0.37%	0.47%	0.44%	0.42%	0.38%
Selling, General & Admin	352.65M	369.04M	327.71M	400.41M	280.29M	292.48M	566.49M	576.01M	614.47M	671.11M
SG&A % of Revenue	0.19%	0.2%	0.27%	0.32%	0.32%	0.33%	0.41%	0.4%	0.39%	0.38%
Research & Development	0	0	0	0	0	0	0	0	0	0
R&D % of Revenue	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	0	0	0	0	18.9M	38.46M	78.83M	58.16M	54.59M	4.21M
Operating Income+	-12.14M	138.61M	207.48M	185.99M	110.07M	110.4M	76.75M	168.17M	217.05M	341.54M
Operating Margin %	-0.01%	0.08%	0.17%	0.15%	0.13%	0.12%	0.06%	0.12%	0.14%	0.19%
Operating Income Growth %	-1.08%	12.42%	0.5%	-0.1%	-0.41%	0%	-0.3%	1.19%	0.29%	0.57%
EBITDA+	73.41M	195.59M	260.3M	226.69M	195.13M	144.29M	218.59M	270.79M	292.37M	393.46M
EBITDA Margin %	0.04%	0.11%	0.21%	0.18%	0.23%	0.16%	0.16%	0.19%	0.18%	0.22%
EBITDA Growth %	-0.7%	1.66%	0.33%	-0.13%	-0.14%	-0.26%	0.51%	0.24%	0.08%	0.35%
D&A (Non-Cash Add-back)	85.55M	56.97M	52.82M	40.71M	85.06M	33.89M	141.85M	102.61M	75.32M	51.92M
EBIT	156.76M	200.62M	213.3M	170.22M	224.5M	148.86M	155.57M	226.33M	271.64M	345.75M
Net Interest Income+	-5.27M	-4.24M	-10.98M	-15.93M	-15.82M	-38.74M	-124.97M	-52.52M	-63.66M	-44.1M
Interest Income	666K	4.92M	598K	3.97M	3.69M	4.09M	3.82M	10.65M	0	8.22M
Interest Expense	5.93M	9.14M	11.58M	19.9M	19.51M	42.84M	129.35M	63.17M	63.66M	52.32M
Other Income/Expense	-173.39M	-4.24M	-8.79M	-16.08M	94.92M	-34.63M	-128.24M	-56.13M	-53.12M	-43.03M
Pretax Income+	-17.3M	134.39M	198.68M	170.18M	204.99M	75.77M	-51.49M	112.03M	163.94M	298.51M
Pretax Margin %	-0.01%	0.07%	0.16%	0.14%	0.24%	0.08%	-0.04%	0.08%	0.1%	0.17%
Income Tax+	-14.54M	10.42M	84.1M	34.16M	-14.94M	12.32M	-15.54M	10.28M	26.22M	65.84M
Effective Tax Rate %	0.18%	0.91%	0.17%	0.8%	-0.42%	0.92%	-6.04%	0.83%	0.83%	0.79%
Net Income+	-3.17M	122.28M	33.77M	136.02M	-85.33M	70.03M	310.99M	93.36M	136.78M	237.06M
Net Margin %	-0%	0.07%	0.03%	0.11%	-0.1%	0.08%	0.23%	0.06%	0.09%	0.13%
Net Income Growth %	-1.02%	39.62%	-0.72%	3.03%	-1.63%	1.82%	3.44%	-0.7%	0.47%	0.73%
Net Income (Continuing)	125.5M	120.97M	114.58M	106.87M	219.93M	63.45M	-35.95M	101.75M	137.71M	232.68M
Discontinued Operations	0	2.31M	-80.15M	21.52M	-305.7M	6.58M	346.95M	-8.39M	-936K	4.39M
Minority Interest	5.11M	6.29M	8.32M	9.54M	2.85M	1.79M	0	0	0	0
EPS (Diluted)+	-0.05	1.91	0.54	2.29	4.50	1.49	-3.36	2.05	3.39	6.07
EPS Growth %	-1.02%	39.82%	-0.72%	3.24%	0.97%	-0.67%	-3.26%	1.61%	0.65%	0.79%
EPS (Basic)	-0.05	1.93	0.55	2.32	4.54	1.50	-3.36	2.08	3.47	6.27
Diluted Shares Outstanding	64.37M	64.02M	62.28M	59.33M	54.09M	51.65M	48.39M	45.6M	40.31M	38.33M
Basic Shares Outstanding	64.04M	63.36M	61.46M	58.54M	53.66M	51.32M	48.39M	44.78M	39.41M	37.09M
Dividend Payout Ratio	-	0.09%	-	-	-	-	-	-	-	-

Balance Sheet

	Jun 2016	Jun 2017	Jun 2018	Jun 2019	Jun 2020	Jun 2021	Jun 2022	Jun 2023	Jun 2024	Jun 2025
Total Current Assets+	518.11M	471.21M	688M	504.7M	692.77M	1.51B	557.1M	480.3M	418.08M	416.19M
Cash & Short-Term Investments	311.77M	245.99M	434.94M	308.13M	509.48M	1.32B	365.74M	287.57M	234.4M	213.96M
Cash Only	308.16M	241.98M	430.69M	299.44M	500.52M	1.3B	347.94M	275.07M	221.2M	201.16M
Short-Term Investments	3.61M	4.01M	4.25M	8.68M	8.97M	20.6M	17.8M	12.5M	13.2M	12.8M
Accounts Receivable	162.39M	130.88M	146.73M	66.96M	87.04M	43.04M	81.64M	102.75M	126.83M	146.19M
Days Sales Outstanding	32.15	26.4	43.5	19.71	36.67	17.47	21.56	25.85	29.21	29.84
Inventory	0	0	0	0	0	0	0	0	0	0
Days Inventory Outstanding	-	-	-	-	-	-	-	-	-	-
Other Current Assets	7.18M	63.39M	47.44M	204.22M	45.57M	155.93M	109.73M	89.97M	56.85M	56.04M
Total Non-Current Assets+	1.58B	1.84B	1.66B	1.74B	1.54B	1.57B	2.47B	2.33B	2.32B	2.34B
Property, Plant & Equipment	521.76M	488.83M	388.65M	364.68M	461.04M	451.06M	467.92M	419.33M	425.28M	447.32M
Fixed Asset Turnover	3.53x	3.70x	3.17x	3.40x	1.88x	1.99x	2.95x	3.46x	3.73x	4.00x
Goodwill	588.01M	851.28M	813.89M	874.45M	686.21M	310.21M	961.26M	961.26M	961.26M	961.26M
Intangible Assets	342.86M	413.8M	362.93M	418.1M	287.51M	137.5M	873.58M	812.34M	776.69M	765.47M
Long-Term Investments	40.75M	21.8M	23.1M	25.1M	56.1M	69.79M	68.84M	27.04M	26.13M	64.66M
Other Non-Current Assets	32.91M	33.34M	29.61M	37.35M	22.78M	547.84M	50.44M	53.59M	84.88M	64.49M
Total Assets+	2.1B	2.31B	2.34B	2.24B	2.23B	3.08B	3.03B	2.81B	2.74B	2.75B
Asset Turnover	0.88x	0.78x	0.53x	0.55x	0.39x	0.29x	0.46x	0.52x	0.58x	0.65x
Asset Growth %	0.01%	0.1%	0.01%	-0.04%	-0.01%	0.38%	-0.02%	-0.07%	-0.02%	0%
Total Current Liabilities+	361.84M	377.33M	365.78M	311.63M	345.98M	408.81M	423.65M	431.2M	487.66M	507.93M
Accounts Payable	64.69M	43.08M	47.48M	53.38M	46.48M	42.42M	57.14M	81.81M	102.63M	105.02M
Days Payables Outstanding	23.93	16.34	26.84	31.25	37.11	33.81	31.61	46.05	53.62	49.69
Short-Term Debt	0	0	3M	3M	54.64M	56.99M	50.78M	37.67M	31.43M	35.16M
Deferred Revenue (Current)	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K
Other Current Liabilities	0	257.34M	137.24M	208.58M	52.79M	186.26M	98.12M	105.81M	96.96M	77.29M
Current Ratio	1.43x	1.25x	1.88x	1.62x	2.00x	3.71x	1.32x	1.11x	0.86x	0.82x
Quick Ratio	1.43x	1.25x	1.88x	1.62x	2.00x	3.71x	1.32x	1.11x	0.86x	0.82x
Cash Conversion Cycle	-	-	-	-	-	-	-	-	-	-
Total Non-Current Liabilities+	147.96M	261.38M	450.78M	529.99M	569.43M	1.37B	1.12B	922M	884.63M	810.8M
Long-Term Debt	0	125M	290.07M	398.09M	286.12M	1.07B	838.91M	695.08M	648.71M	552.67M
Capital Lease Obligations	0	0	0	0	176.03M	167.07M	177.04M	163.44M	167.71M	186.17M
Deferred Tax Liabilities	29.94M	34.71M	29.11M	29.43M	24.98M	26.18M	25.55M	26.07M	29.53M	31.86M
Other Non-Current Liabilities	118.03M	102.66M	131.6M	102.47M	82.31M	112.22M	73.7M	37.42M	38.67M	15.1M
Total Liabilities	509.8M	638.71M	816.57M	841.62M	915.41M	1.78B	1.54B	1.35B	1.37B	1.32B
Total Debt+	0	125M	293.07M	401.09M	568.43M	1.29B	1.07B	896.19M	847.85M	774M
Net Debt	-308.16M	-116.98M	-137.62M	101.65M	67.92M	-3.61M	718.8M	621.12M	626.65M	572.84M
Debt / Equity	-	0.07x	0.19x	0.29x	0.43x	0.99x	0.72x	0.61x	0.62x	0.54x
Debt / EBITDA	-	0.64x	1.13x	1.77x	2.91x	8.95x	4.88x	3.31x	2.90x	1.97x
Net Debt / EBITDA	-4.20x	-0.60x	-0.53x	0.45x	0.35x	-0.03x	3.29x	2.29x	2.14x	1.46x
Interest Coverage	-2.05x	15.16x	17.92x	9.35x	5.64x	2.58x	0.59x	2.66x	3.41x	6.53x
Total Equity+	1.59B	1.68B	1.53B	1.4B	1.31B	1.3B	1.49B	1.46B	1.37B	1.43B
Equity Growth %	-0%	0.06%	-0.09%	-0.08%	-0.06%	-0.01%	0.14%	-0.02%	-0.06%	0.05%
Book Value per Share	24.66	26.17	24.54	23.61	24.28	25.23	30.82	31.96	33.97	37.40
Total Shareholders' Equity	1.58B	1.67B	1.52B	1.39B	1.31B	1.3B	1.49B	1.46B	1.37B	1.43B
Common Stock	765K	781K	793K	801K	807K	811K	818K	822K	832K	839K
Retained Earnings	1.77B	1.88B	1.92B	2.01B	1.93B	2.01B	2.31B	2.4B	2.54B	2.78B
Treasury Stock	-519.45M	-569.93M	-711.37M	-970.94M	-1.11B	-1.22B	-1.34B	-1.51B	-1.78B	-2.01B
Accumulated OCI	-42.47M	-59.12M	-142.17M	-137.29M	-9.05M	-7.37M	-2.23M	-2.23M	-2.23M	-2.23M
Minority Interest	5.11M	6.29M	8.32M	9.54M	2.85M	1.79M	0	0	0	0

Cash Flow

	Jun 2016	Jun 2017	Jun 2018	Jun 2019	Jun 2020	Jun 2021	Jun 2022	Jun 2023	Jun 2024	Jun 2025
Cash from Operations+	231.57M	227.96M	239.19M	204.86M	107.69M	192.2M	10.6M	191.91M	295.77M	337.9M
Operating CF Margin %	0.13%	0.13%	0.19%	0.17%	0.12%	0.21%	0.01%	0.13%	0.19%	0.19%
Operating CF Growth %	0.14%	-0.02%	0.05%	-0.14%	-0.47%	0.78%	-0.94%	17.1%	0.54%	0.14%
Net Income	-2.76M	123.28M	114.44M	136.02M	71.39M	70.03M	-35.95M	101.75M	137.71M	237.06M
Depreciation & Amortization	85.55M	84.06M	52.82M	51.74M	100.97M	84.54M	186.6M	151.09M	107.96M	84.47M
Stock-Based Compensation	22.37M	16.6M	14.5M	13.22M	13.88M	12.82M	22.61M	14.3M	25.95M	41.59M
Deferred Taxes	-41.65M	5.6M	-10.6M	20.76M	-4.55M	62K	-544K	-5.09M	11.07M	18.41M
Other Non-Cash Items	236.8M	101.47M	86.11M	29.56M	36.17M	32.23M	-78.91M	33.65M	65.99M	70.94M
Working Capital Changes	-68.75M	-103.05M	-18.09M	-46.45M	-110.18M	-7.48M	-83.2M	-103.79M	-52.91M	-114.58M
Change in Receivables	-91.65M	-100.12M	-43.29M	-27.71M	-12.84M	13.26M	-41.39M	-56.31M	-76.36M	-80.82M
Change in Inventory	20.09M	-5.97M	11.86M	-17.85M	-71.64M	-22.63M	0	0	0	0
Change in Payables	-9.61M	755K	9.96M	9.2M	-6.34M	8.53M	-15.72M	24.74M	18.33M	140K
Cash from Investing+	-215.41M	-379.65M	-71.45M	-213.84M	382.52M	-56.69M	-551.8M	23.74M	-47.85M	-41.92M
Capital Expenditures	-69.4M	-48.99M	-66.53M	-64.75M	-44.14M	-48.66M	-31.05M	-26.01M	-48.89M	-50.33M
CapEx % of Revenue	0.04%	0.03%	0.05%	0.05%	0.05%	0.05%	0.02%	0.02%	0.03%	0.03%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	31.07M	-48.99M	-62.25M	-26.2M	271.99M	-48.66M	967.48M	43.63M	0	0
Cash from Financing+	-65.62M	88.8M	37.2M	-137.53M	-256.11M	676.47M	-424.48M	-288.51M	-301.8M	-316.02M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	-22.98M	-11.41M	0	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	1.49M	28.54M	3.44M	15.12M	-11.42M	-16.33M	-74.76M	-14.52M	10.17M	-14.2M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	162.17M	178.97M	172.66M	140.11M	63.55M	143.53M	-20.45M	165.9M	246.88M	287.57M
FCF Margin %	0.09%	0.1%	0.14%	0.11%	0.07%	0.16%	-0.01%	0.11%	0.16%	0.16%
FCF Growth %	0.42%	0.1%	-0.04%	-0.19%	-0.55%	1.26%	-1.14%	9.11%	0.49%	0.16%
FCF per Share	2.52	2.80	2.77	2.36	1.17	2.78	-0.42	3.64	6.13	7.50
FCF Conversion (FCF/Net Income)	-73.14x	1.86x	7.08x	1.51x	-1.26x	2.74x	0.03x	2.06x	2.16x	1.43x
Interest Paid	3.51M	7.33M	11.51M	20.41M	20.16M	14.43M	107.09M	53.13M	57.84M	46.6M
Taxes Paid	-1.42M	14.9M	8.37M	3.23M	12.44M	26.43M	94.36M	12.31M	31.48M	32.78M

Key Ratios

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Return on Equity (ROE)	-0.2%	7.5%	2.11%	9.29%	-6.29%	5.35%	22.26%	6.33%	9.68%	16.92%
Return on Invested Capital (ROIC)	-0.72%	7.33%	10.55%	9.64%	5.72%	6.18%	3.28%	5.88%	7.99%	12.8%
Gross Margin	46.47%	46.83%	47.56%	49.7%	47.24%	49.08%	52.25%	55.3%	55.92%	56.86%
Net Margin	-0.17%	6.76%	2.74%	10.97%	-9.85%	7.79%	22.51%	6.43%	8.63%	13.26%
Debt / Equity	-	0.07x	0.19x	0.29x	0.43x	0.99x	0.72x	0.61x	0.62x	0.54x
Interest Coverage	-2.05x	15.16x	17.92x	9.35x	5.64x	2.58x	0.59x	2.66x	3.41x	6.53x
FCF Conversion	-73.14x	1.86x	7.08x	1.51x	-1.26x	2.74x	0.03x	2.06x	2.16x	1.43x
Revenue Growth	-3.48%	-1.83%	-31.97%	0.69%	-30.11%	3.79%	53.67%	4.99%	9.22%	12.85%

Revenue by Segment

	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Chamberlain	-	-	-	-	-	-	557.54M	571.03M	633.52M	725.77M
Chamberlain Growth	-	-	-	-	-	-	-	2.42%	10.94%	14.56%
Walden University	-	-	-	-	-	-	485.39M	533.73M	595.33M	693.43M
Walden University Growth	-	-	-	-	-	-	-	9.96%	11.54%	16.48%
Medical and Veterinary	-	-	-	-	-	-	344.19M	346.07M	355.8M	369.09M
Medical and Veterinary Growth	-	-	-	-	-	-	-	0.54%	2.81%	3.73%
Medical And Healthcare	936.33M	802.46M	815.67M	849.86M	866.43M	906.9M	-	-	-	-
Medical And Healthcare Growth	-	-14.30%	1.65%	4.19%	1.95%	4.67%	-	-	-	-
Financial Services	-	-	-	-	185.57M	205.48M	-	-	-	-
Financial Services Growth	-	-	-	-	-	10.73%	-	-	-	-
Business And Law	-	-	-	225.84M	-	-	-	-	-	-
Business And Law Growth	-	-	-	-	-	-	-	-	-	-
Financial Service	-	-	-	167.21M	-	-	-	-	-	-
Financial Service Growth	-	-	-	-	-	-	-	-	-	-
Home Office And Other	-	-	-2.59M	-3.23M	-	-	-	-	-	-
Home Office And Other Growth	-	-	-	-24.58%	-	-	-	-	-	-
Technology And Business	-	276.34M	270.93M	-	-	-	-	-	-	-
Technology And Business Growth	-	-	-1.96%	-	-	-	-	-	-	-
Professional Education	-	131.77M	147.19M	-	-	-	-	-	-	-
Professional Education Growth	-	-	11.71%	-	-	-	-	-	-	-
U.s. Traditional Postsecondary	-	601.92M	-	-	-	-	-	-	-	-
U.s. Traditional Postsecondary Growth	-	-	-	-	-	-	-	-	-	-
Business Technology And Management	611.13M	-	-	-	-	-	-	-	-	-
Business Technology And Management Growth	-	-	-	-	-	-	-	-	-	-
International K Twelve And Professional Education	299.02M	-	-	-	-	-	-	-	-	-
International K Twelve And Professional Education Growth	-	-	-	-	-	-	-	-	-	-
Intersegment Revenues	-2.94M	-	-	-	-	-	-	-	-	-
Intersegment Revenues Growth	-	-	-	-	-	-	-	-	-	-

Revenue by Geography

	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Domestic Operations	1.29B	1.19B	610.97M	640.73M	651.34M	717.97M	1.04B	1.1B	1.23B	1.42B
Domestic Operations Growth	-	-8.25%	-48.56%	4.87%	1.66%	10.23%	45.26%	5.93%	11.23%	15.49%
Barbados, St. Kitts, and St. Maarten	-	-	-	-	-	-	-	-	355.8M	369.09M
Barbados, St. Kitts, and St. Maarten Growth	-	-	-	-	-	-	-	-	-	3.73%
Barbados, Dominica, St. Kitts and St. Maarten	-	-	-	-	-	-	344.19M	346.07M	-	-
Barbados, Dominica, St. Kitts and St. Maarten Growth	-	-	-	-	-	-	-	0.54%	-	-
Barbados Dominica St. Kitts And St. Maarten	-	-	-	362.43M	354.77M	343.09M	-	-	-	-
Barbados Dominica St. Kitts And St. Maarten Growth	-	-	-	-	-2.11%	-3.29%	-	-	-	-
Dominica And S T Kitts Nevis	346.24M	340.86M	342.83M	-	-	-	-	-	-	-
Dominica And S T Kitts Nevis Growth	-	-1.55%	0.58%	-	-	-	-	-	-	-
BRAZIL	196.1M	276.34M	270.93M	-	-	-	-	-	-	-
BRAZIL Growth	-	40.92%	-1.96%	-	-	-	-	-	-	-

Frequently Asked Questions

Valuation & Price

Adtalem Global Education Inc. (ATGE) has a price-to-earnings (P/E) ratio of 19.3x. This is roughly in line with market averages.

Growth & Financials

Adtalem Global Education Inc. (ATGE) reported $1.83B in revenue for fiscal year 2025. This represents a 12% decrease from $2.09B in 2012.

Adtalem Global Education Inc. (ATGE) grew revenue by 12.9% over the past year. This is steady growth.

Yes, Adtalem Global Education Inc. (ATGE) is profitable, generating $252.0M in net income for fiscal year 2025 (13.3% net margin).

Dividend & Returns

Adtalem Global Education Inc. (ATGE) has a return on equity (ROE) of 16.9%. This is reasonable for most industries.

Adtalem Global Education Inc. (ATGE) generated $323.2M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

US Stock Screener

...